Andrea Sánchez de la Cruz
banner
asancru.bsky.social
Andrea Sánchez de la Cruz
@asancru.bsky.social
Studying EBV-specific immune response in multiple sclerosis at @cnb-csic.bsky.social
Reposted by Andrea Sánchez de la Cruz
La iniciativa «Comparte tu perspectiva y amplía los horizontes del CNB», del Programa Sinergias #SeveroOchoa apoyará las propuestas de 3 grupos de 25 jóvenes del #CNB
Más info: https://f.mtr.cool/ycjtpsjhlb
@csic.es
December 29, 2025 at 10:15 AM
Reposted by Andrea Sánchez de la Cruz
Common virus jab could be key in fight against multiple sclerosis

The vaccine will be trialled in patients recently diagnosed with MS

www.independent.co.u...
1/3
Common virus jab could be key in fight against multiple sclerosis
The vaccine will be trialled in patients recently diagnosed with MS
www.independent.co.uk
November 21, 2025 at 6:52 PM
Reposted by Andrea Sánchez de la Cruz
All MS patients share increased inflammatory B and T cells, but differ in regulatory or NK subsets, which identify highly inflammatory or benign disease courses
www.frontiersin.org/journals/imm... @frontiersin.bsky.social
August 27, 2025 at 1:59 AM
Today was the last day of the course, focused on the dual role of microglia. Its “foamy” phenotype, after phagocytosing damaged myelin, becomes proinflammatory. The purinergic receptor P2X4 was highlighted, as well as the potential of drugs like ivermectin to modulate its response #MS_UIMP25
June 20, 2025 at 8:06 PM
Second day at #UIMP, discussing aging in #MS: biomarkers of axonal damage #NfL and inflammation #GFAP, and the impact of immunosenescence with experts like María Villar. We also had a moment to enjoy a bit of sunshine around the Palacio de la Magdalena, Santander #MS_UIMP25
June 19, 2025 at 6:39 PM
Third time attending this multiple sclerosis #MS meeting at #UIMP, this year focusing on the new diagnostic criteria, aging, and the role of microglia. #MS_UIMP25
June 18, 2025 at 3:07 PM